Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Lucid Diagnostics Inc. (NASDAQ: LUCD)
LUCD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
123.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
105.50%
LUCD Stock Analysis
LUCD
PE Ratio:
LUCD
PEG Ratio:
Not Available
LUCD
Forward EPS Growth (12 month):
0.00%
LUCD
PS Ratio:
20
LUCD
PSG Ratio:
0.1
LUCD
Forward Revenue Growth (12 month):
145.40%
LUCD Articles
No data was found